Name | lithium,9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate |
---|---|
Synonyms |
Lithium mupirocin
Li-MUP Pseudomonic acid A lithium salt 9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt Lithium mupirocin Supplement Lithium mupirocin solution |
Description | Mupirocin (BRL-4910A) lithium is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin lithium apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2][3][4][5]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C26H43LiO9 |
---|---|
Molecular Weight | 506.56 |
Exact Mass | 500.29900 |
PSA | 146.05000 |
LogP | 2.59250 |
RIDADR | NONH for all modes of transport |
---|